[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MY8600311A - Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them - Google Patents

Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them

Info

Publication number
MY8600311A
MY8600311A MY311/86A MY8600311A MY8600311A MY 8600311 A MY8600311 A MY 8600311A MY 311/86 A MY311/86 A MY 311/86A MY 8600311 A MY8600311 A MY 8600311A MY 8600311 A MY8600311 A MY 8600311A
Authority
MY
Malaysia
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
peptide alkaloids
ergot peptide
Prior art date
Application number
MY311/86A
Other languages
English (en)
Inventor
Hans Kobel
Jean-Jacques Sanglier
Hans Tscherter
Georg Bolliger
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of MY8600311A publication Critical patent/MY8600311A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
MY311/86A 1981-08-07 1986-12-30 Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them MY8600311A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH5104/81A CH649300A5 (de) 1981-08-07 1981-08-07 Ergopeptinderivate, ihre herstellung und verwendung.

Publications (1)

Publication Number Publication Date
MY8600311A true MY8600311A (en) 1986-12-31

Family

ID=4287999

Family Applications (1)

Application Number Title Priority Date Filing Date
MY311/86A MY8600311A (en) 1981-08-07 1986-12-30 Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them

Country Status (27)

Country Link
US (3) US4542135A (de)
JP (1) JPS5843982A (de)
AT (1) AT382156B (de)
AU (1) AU558414B2 (de)
BE (1) BE894046A (de)
CA (1) CA1191802A (de)
CH (1) CH649300A5 (de)
CS (1) CS235303B2 (de)
DD (2) DD211582A5 (de)
DE (1) DE3228230A1 (de)
DK (1) DK352082A (de)
ES (2) ES8402348A1 (de)
FI (1) FI72979C (de)
FR (1) FR2511003B1 (de)
GB (1) GB2109795B (de)
GR (1) GR77262B (de)
HU (2) HU190405B (de)
IE (1) IE53647B1 (de)
IL (1) IL66471A (de)
IT (1) IT1152489B (de)
MY (1) MY8600311A (de)
NL (1) NL8203067A (de)
NZ (1) NZ201504A (de)
PH (1) PH22998A (de)
PT (1) PT75384B (de)
SE (1) SE452011B (de)
ZA (1) ZA825727B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.
JPS60104129A (ja) * 1983-11-11 1985-06-08 Hitachi Ltd フッ素含有ポリアミド酸誘導体及びポリイミドの製造方法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
HU193317B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing 2-bromo-alpha-ergochristin
DE69330601T2 (de) * 1992-12-24 2002-07-04 Pharmacia & Upjohn S.P.A., Mailand/Milano Serotoninergische ergolin derivate
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361258A1 (de) * 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von substituierten 2-Aminotetralinen zur vorbeugenden Behandlung von Morbus Parkinson
US20050197385A1 (en) * 2004-02-20 2005-09-08 Schwarz Pharma Ag Use of rotigotine for treatment or prevention of dopaminergic neuron loss
DE102004014841B4 (de) * 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
US20070022720A1 (en) * 2005-07-27 2007-02-01 The Toro Company Cleaner for cooling system screen of outdoor power equipment unit
SG181896A1 (en) * 2009-12-23 2012-07-30 Map Pharmaceuticals Inc Novel ergoline analogs
BR112013033339A2 (pt) 2011-06-23 2016-08-16 Map Pharmaceuticals Inc análogos de fluorergolina
AU2012355982A1 (en) 2011-12-19 2014-07-10 Map Pharmaceuticals, Inc. Novel iso-ergoline derivatives
US8946420B2 (en) 2011-12-21 2015-02-03 Map Pharmaceuticals, Inc. Neuromodulatory compounds
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
CZ2013590A3 (cs) * 2013-07-25 2014-09-03 Teva Czech Industries S.R.O. Izolovaný kmen houby Claviceps purpurea (Fr.) Tul., CCM 8404
CN113308442B (zh) * 2021-04-28 2023-06-27 天津大学 重组酿酒酵母菌株及其构建方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314959A (en) * 1961-05-10 1967-04-18 Sandoz Ltd Intermediates for the synthesis of ergot alkaloids
FR2292M (fr) * 1962-06-27 1964-01-27 Sandoz Sa Médicament a base d'une combinaison de dihydro-ergotamine, de caféine et d'une hydantoine.
CH602765A5 (de) * 1974-09-27 1978-07-31 Sandoz Ag
CH602766A5 (en) * 1974-09-27 1978-07-31 Sandoz Ag 10-Alpha-methoxy-di:hydro-beta-ergosine derivs.
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
CH626373A5 (de) * 1977-02-22 1981-11-13 Sandoz Ag
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
DE2717953A1 (de) * 1977-04-22 1978-10-26 Sandoz Ag Neue therapeutische mischung und verfahren zu deren herstellung
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
CH636011A5 (en) * 1978-01-01 1983-05-13 Sandoz Ag Administration forms for organic compounds
DE2962303D1 (en) * 1978-01-20 1982-04-29 Sandoz Ag Derivatives of ergopeptide alkaloids, process for their preparation and pharmaceutical compositions containing them
DE2803543A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Ergopeptidalkaloidderivate, ihre verwendung und herstellung
YU40046B (en) * 1978-09-04 1985-06-30 Lek Tovarna Farmacevtskih Process for preparing 2-bromo-9,10-dihydroergosine
US4609731A (en) * 1979-10-10 1986-09-02 Sandoz Ltd. Process for brominating ergot alkaloids
DD200571A1 (de) * 1981-07-22 1983-05-18 Alfred Baumert Verfahren zur herstellung von ergopeptinen mit modifiziertem prolinteil
CH649300A5 (de) * 1981-08-07 1985-05-15 Sandoz Ag Ergopeptinderivate, ihre herstellung und verwendung.

Also Published As

Publication number Publication date
IT1152489B (it) 1986-12-31
JPH0437836B2 (de) 1992-06-22
FI72979C (fi) 1987-08-10
HU190405B (en) 1986-09-29
ES514766A0 (es) 1984-01-16
ES8402348A1 (es) 1984-01-16
DE3228230A1 (de) 1983-02-17
ES526119A0 (es) 1985-04-16
CS235303B2 (en) 1985-05-15
ZA825727B (en) 1984-03-28
PH22998A (en) 1989-02-24
GB2109795A (en) 1983-06-08
AU8678582A (en) 1983-03-03
DD206379A5 (de) 1984-01-25
DK352082A (da) 1983-02-08
GR77262B (de) 1984-09-11
FI72979B (fi) 1987-04-30
NL8203067A (nl) 1983-03-01
ES8504825A1 (es) 1985-04-16
IL66471A0 (en) 1982-12-31
NZ201504A (en) 1986-08-08
PT75384A (en) 1982-09-01
BE894046A (fr) 1983-02-07
US4542135A (en) 1985-09-17
HUT37960A (en) 1986-03-28
IE53647B1 (en) 1989-01-04
IT8222768A0 (it) 1982-08-06
FR2511003A1 (fr) 1983-02-11
IL66471A (en) 1986-02-28
SE452011B (sv) 1987-11-09
SE8204585D0 (sv) 1982-08-05
CA1191802A (en) 1985-08-13
FI822670L (fi) 1983-02-08
ATA302682A (de) 1986-06-15
US4681880A (en) 1987-07-21
SE8204585L (sv) 1983-02-08
PT75384B (en) 1985-06-28
US4804660A (en) 1989-02-14
FR2511003B1 (fr) 1986-12-05
JPS5843982A (ja) 1983-03-14
DD211582A5 (de) 1984-07-18
IE821906L (en) 1983-02-07
AT382156B (de) 1987-01-26
HU193373B (en) 1987-09-28
FI822670A0 (fi) 1982-07-30
AU558414B2 (en) 1987-01-29
CH649300A5 (de) 1985-05-15
GB2109795B (en) 1985-07-03

Similar Documents

Publication Publication Date Title
IL66099A0 (en) N-aryl-piperazinealkanamides,their preparation and pharmaceutical compositions containing them
IL65257A0 (en) Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them
IL67206A0 (en) Bicyclic compounds,their preparation and pharmaceutical compositions containing them
IL65814A0 (en) Benzazepine derivatives,their preparation and pharmaceutical compositions containing them
IL65803A (en) Cyclobutene-dione derivatives,their preparation and pharmaceutical compositions containing them
GB2109795B (en) Ergot peptide alkaloids, their preparation and pharmaceutical compositions containing them
IL64777A0 (en) 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them
IL66408A (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL66683A0 (en) Benzo-heterocycles,their preparation and pharmaceutical compositions containing them
IL67180A0 (en) Morphinate derivatives,their preparation and pharmaceutical compositions containing them
DE3264121D1 (en) Ergoline derivatives, processes for their preparation and pharmaceutical compositions containing them
IL74244A (en) Quinoline derivatives,their preparation and pharmaceutical compositions containing them
IL65051A0 (en) Azepine derivatives,their preparation and pharmaceutical compositions containing them
IL71633A (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
IL66424A (en) 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them
IL65327A0 (en) Acylquinolinone derivatives,their preparation and pharmaceutical compositions containing them
IL66113A0 (en) Pharmaceutical formulations containing ergot alkaloids
IL67155A (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
IL66238A0 (en) Benzothiazolesulfonamide derivatives,their preparation and pharmaceutical compositions containing them
IL65422A (en) 2-piperazino-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them
IL68496A0 (en) Ergoline derivatives,their preparation and pharmaceutical compositions containing them
IL65177A0 (en) Fluoroprostacylins,their preparation and pharmaceutical compositions containing them
IL69450A0 (en) Ergot alkaloids,their production and pharmaceutical compositions containing them
IL62519A (en) Ergoline 8-carbonylurea derivatives,their preparation and pharmaceutical compositions containing them
IL56457A0 (en) Ergot peptide alkaloid derivatives, their preparation and pharmaceutical compositions containing them